HT
AXSM icon

HAP Trading’s Axsome Therapeutics AXSM Stock Holding History

HAP Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,580
Closed -$359K – 2218
2021
Q4 		$437K Sell
11,580
-3,963
-25% -$146K 0.01% 737
2021
Q3 		$512K Sell
15,543
-4,277
-22% -$167K 0.02% 673
2021
Q2 		$1.34M Buy
+19,820
New +$1.19M 0.04% 375
2020
Q2 		– Sell
-13,645
Closed -$1.05M – 1682
2020
Q1 		$803K Buy
+13,645
New +$1.11M 0.05% 255

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

HAP Trading's AXSM Position: Q1 2022 in Review

HAP Trading sold out of Axsome Therapeutics (AXSM) in Q1 2022, closing a stake of 11,580 shares — an estimated $359K sold.

HAP Trading first reported a position in AXSM in Q1 2020 and held it in 4 quarters. The position peaked at $1.34M in Q2 2021. 175 funds tracked by Wall St. Rank hold AXSM as of Q1 2022.

  • HAP Trading reported no remaining Axsome Therapeutics position as of Q1 2022 after selling out during the quarter.
  • HAP Trading sold 11,580 Axsome Therapeutics shares in Q1 2022, an estimated $359K.
  • HAP Trading first reported a position in Axsome Therapeutics in Q1 2020 and held it in 4 quarters.
  • HAP Trading's Axsome Therapeutics position peaked at $1.34M in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.